Y. Motoo, K. Shinozaki, T. Takagi, Shingo Ito, H. Fujita, Y. Munemoto, Naohisa Yoshida, E. Baba, Y. Shindo, T. Nishiuchi, M. Miura, S. Morita, A. Tsuji
{"title":"联合Ninjin’yoeito在CapeOX + Bmab治疗不可切除晚期/复发结直肠癌患者中的意义的随机对照试验","authors":"Y. Motoo, K. Shinozaki, T. Takagi, Shingo Ito, H. Fujita, Y. Munemoto, Naohisa Yoshida, E. Baba, Y. Shindo, T. Nishiuchi, M. Miura, S. Morita, A. Tsuji","doi":"10.1097/md9.0000000000000196","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":325445,"journal":{"name":"Medicine: Case Reports and Study Protocols","volume":"88 13","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Randomized controlled trial of the significance of combined use with Ninjin’yoeito in CapeOX + Bmab therapy for patients with unresectable advanced/recurrent colorectal cancer\",\"authors\":\"Y. Motoo, K. Shinozaki, T. Takagi, Shingo Ito, H. Fujita, Y. Munemoto, Naohisa Yoshida, E. Baba, Y. Shindo, T. Nishiuchi, M. Miura, S. Morita, A. Tsuji\",\"doi\":\"10.1097/md9.0000000000000196\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":325445,\"journal\":{\"name\":\"Medicine: Case Reports and Study Protocols\",\"volume\":\"88 13\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicine: Case Reports and Study Protocols\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/md9.0000000000000196\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine: Case Reports and Study Protocols","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/md9.0000000000000196","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Randomized controlled trial of the significance of combined use with Ninjin’yoeito in CapeOX + Bmab therapy for patients with unresectable advanced/recurrent colorectal cancer